New program aims to help asian american smokers quit and catch lung cancer early

NCT ID NCT06945120

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a program designed specifically for Chinese and Korean American smokers who are at high risk for lung cancer. The program includes counseling sessions, family coaching, nicotine replacement therapy (like patches or gum), and information about lung cancer screening. Researchers want to see if this culturally tailored approach helps more people quit smoking and get screened.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention (counseling, family coaching, nicotine replacement therapy, and educational materials)
What this could lead to
If successful, this program could provide an effective, culturally sensitive way to help Chinese and Korean American smokers quit and get screened for lung cancer.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to all smokers. Quitting smoking is difficult, and the program may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMOKING ( CIGARETTE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive Cigarette Smoking nicotine dependence Smoking Smoking Cessation Tobacco Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • University of Massachusetts-Boston

    RECRUITING

    Boston, Massachusetts, 02125, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.